Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?

The vaccine is personalized to a patient's tumor, and results from the Phase 3 trial are yet another example of the promise of mRNA vaccines in treating cancer. The new mRNA vaccine is waiting on FDA approval but has shown great promise in Phase 3 clinical trials. An experimental vaccine offers new hope to patients with melanoma, one of the most aggressive forms of skin cancer . The pharmaceutical companies Merck and Moderna released the results of a Phase 3 clinical trial that evaluated the efficacy of a personalized mRNA-based vaccine that, when combined with immunotherapy, reduced the risk of disease recurrence or death by 42 percent compared to treatment with the immunotherapy drug alone. Georgina Long, medical director of the Australian Melanoma Institute and the study's principal investigator, said in a statement that these results are "transformative" and "have the potential to make a foundational shift in how we treat patients with earlier-stage melanoma."

Follow this section to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Follow this tag to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW?

In unraveling the pathways by which movement helps the body, we could develop medicines that offer some of the same benefits, without the workout. We all know exercise is good for us. It builds muscle, strengthens bones, lowers blood pressure, and boosts mood. By deciphering how movement benefits the body, researchers hope to develop medicines that can offer some of the same perks--without the workout. The idea isn't to replace exercise but to bring its upsides to people who struggle with frailty, disability, or chronic illness. It will take a lot of experimentation to untangle the myriad pathways by which exercise promotes health.

Say More Versus Trending Now Look Up In My Bag Mashable's Best: E-readers, robovacs, laptops, earbuds, smart home and more Mashable @Home Mashable Selects Top creators, ranked Gift Ideas For Everyone On Your List Creator Playbook AI at School All Series Influencers are shilling libido products. Which ones should you use? Experts break down what's worth your time and money. Anna Iovine is the associate editor of features at Mashable. Previously, as the sex and relationships reporter, she covered topics ranging from dating apps to pelvic pain. Before Mashable, Anna was a social editor at VICE and freelanced for publications such as Slate and the Columbia Journalism Review.

Follow this author to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Solius Pro brings the health benefits of outdoor sunlight into the home with the first over-the-counter FDA-cleared UVB-light therapy panel to help stimulate vitamin D production in the body without risk of sun damage. Use of this site constitutes acceptance of our Terms of Service, Privacy Policy and .

Follow this author to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. Sweeney is a contributor for TIME. Structural heart disease affects millions of people worldwide, yet it often goes undetected until it progresses because there's no affordable routine screening.

The device made by Flow Neuroscience is approved by the FDA and could help people get off antidepressants--but it costs $2,200. An at-home wearable for the treatment of depression is now available by prescription in the US. With roughly one in six American adults taking an antidepressant medication, Swedish firm Flow Neuroscience is positioning its device as an alternative to traditional drugs. But at the current four-figure price tag, it might take a while for the futuristic-looking headset to catch on with patients. Worn on the forehead for 30 minutes a day and operated with an app, the device provides low-intensity electrical stimulation to the left frontal lobe of the brain, an area involved in regulating mood and emotions.

This material may not be published, broadcast, rewritten, or redistributed. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset . Powered and implemented by FactSet Digital Solutions . Mutual Fund and ETF data provided by LSEG . Asked Siri to call your bank? Floating solar panels could save cities millions. Amazon's Alexa for Shopping can now verify suspicious messages Should you use a separate computer for online banking? Tech companies begging for regulation seems like'Trojan horse,' Vance says Americans are right to be scared over'God in a box,' AI CEO says AI policy expert dismisses Big Tech regulation calls: 'We should see through this' AI agents are'hacking out of the container' despite best efforts to prevent it, expert warns'Totally legitimate' to be concerned about AI: Mollie Hemingway Iran opening'second front' with Houthis in Yemen, Rep Crawford warns White House advisor calls on tech leaders to'stop pretending' over AI threat Kyrsten Sinema: Trump has been'tremendous' on AI data centers CEO of Sellas Life Sciences Angelos Stergiou explains how AI is revolutionizing medicine by enabling precision medicine in cancer treatment.

Follow this author to personalize your feed and get instant alerts. Follow Go to your personalized feed WHY FOLLOW? Smart Alerts: Get notified about major news as it happens. When there are breakthrough technologies like xenotransplants, or novel cancer therapies, they're transformative for diseases and conditions once thought incurable--but they can only save lives if the people that need them can access them. On September 10, TIME hosted the third annual TIME100 Health Leadership Forum in New York City, bringing together the TIME and TIME100 Health communities to discuss equity, longevity, and solution-driven care.